As Zimbabwe moves to reduce a pharmaceutical import bill exceeding US$300 million annually, local manufacturer Varichem Pharmaceuticals is expanding production and regional exports, positioning itself as a key player in the country's drive towards medicine self-sufficiency.

The pharmaceutical company is currently operating at more than 70 percent capacity utilisation, reflecting growing demand for locally manufactured medicines and signalling a shift towards domestic production at a time when Government is tightening measures to promote local industry.

Zimbabwe continues to spend significant amounts of foreign currency importing products that could potentially be produced locally, a situation policymakers and economists say is unsustainable.

Economist Gift Mugano recently highlighted the scale of the challenge, noting that Zimbabwe spends more than US$200 million annually importing tissue paper and over US$300 million on pharmaceuticals despite having the capacity to manufacture many of these products domestically.

"We cannot continue importing products such as toothpicks, chewing gum, tissue paper and pharmaceuticals when we have the potential to produce many of them locally," said Mugano.

Against this backdrop, Varichem's growth is increasingly being viewed as part of the solution to reducing import dependence while strengthening Zimbabwe's pharmaceutical value chain.

The company is not only supplying the local market but is also exporting a wide range of pharmaceutical products to Botswana, South Africa and Zambia, helping raise Zimbabwe's profile as a producer of quality medicines within the region.

To strengthen production capacity and improve competitiveness, Varichem has invested more than US$3 million in plant and machinery upgrades aimed at enhancing manufacturing efficiency, product quality and compliance with international standards.

The investment is expected to improve the company's ability to compete in both domestic and export markets while contributing to the country's broader industrialisation and import substitution agenda.

Permanent Secretary in the Ministry of Industry and Commerce Ambassador Thomas Chifamba commended Varichem Pharmaceuticals for its continued investment in local manufacturing, export development and contribution to Zimbabwe's pharmaceutical value chain.

He stated  country’s commitment is to engaging relevant stakeholders to improve the operating environment for local industry and assured Varichem and other players in the sector of strengthened collaboration between Government and industry.

Ambassador Chifamba also underscored the importance of the pharmaceutical sector in advancing Zimbabwe's industrialisation agenda, describing it as a strategic industry capable of creating jobs, generating export earnings and strengthening national healthcare systems.

The expansion of local pharmaceutical manufacturing comes at a time when many countries are seeking to reduce vulnerabilities associated with imported medicines and build stronger domestic production capabilities.

For Zimbabwe, the growth of companies such as Varichem offers more than industrial expansion. It represents an opportunity to improve medicine availability, retain foreign currency, create skilled employment and develop a pharmaceutical sector capable of serving both local and regional markets.

With production levels rising, exports expanding and fresh investment flowing into manufacturing infrastructure, Varichem is increasingly emerging as a symbol of Zimbabwe's ambition to transform from a major importer of medicines into a competitive producer for the region.